Leveraging digital technology and artificial intelligence to describe the real-world Belgian chronic lymphocytic leukemia patient population : the BE-CLLEAR study
Source
JCO Clinical Cancer Informatics - ISSN 2473-4276-10 (2026) p. 1-11
RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA
Source
Experimental hematology & oncology - ISSN 2162-3619-15:1 (2026) p. 1-6
Strategies to eliminate native T cell receptors for adoptive T cell therapies
Source
Molecular therapy - ISSN 1525-0016- (2026) p.
DRP1 depletion protects NK cells from hypoxia-induced dysfunction
Source
Redox report: communications in free radical research - ISSN 1351-0002-31:1 (2026) p. 1-20
Novel methods for the discovery of disease-associated T cell epitopes in autoimmunity
Source
Methods: a companion to methods in enzymology - ISSN 1046-2023-248 (2026) p. 64-82
From Imaging-to-Omics : a preclinical validation framework for advanced CNS therapeutics in Multiple Sclerosis: integrating in vivo MRI with post-mortem transcriptomics and proteomics
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, 2026,XV, 188 p.
Mesenchymal stromal cells derived from the human amniotic membrane as a therapeutic strategy to counteract neuroinflammation
Source
Roma, Università Cattolica del Sacro Cuore & University of Antwerp, 2026,89, 34 p.
Resilience of human tolerogenic dendritic cells to physiological oxygen supports clinical application : functional stability amidst glycolytic and differentiation shifts
Source
Experimental hematology & oncology - ISSN 2162-3619-15:1 (2026) p. 1-6
Time-series transcriptome analysis of the older adult mouse cochlea after noise-induced hearing loss reveals an acute immune response and recovery-associated pathways
Source
Molecular neurobiology - ISSN 0893-7648-63:1 (2026) p. 1-21
Comparative efficacy of talquetamab vs. real-world physician's choice of treatment in triple-class-exposed relapsed/refractory multiple myeloma : updated analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Source
Advances in therapy : the international journal of drug, device & diagnostic research - ISSN 0741-238X-43:1 (2026) p. 333-355